PDF herunterladen
J Neurol Surg B Skull Base 2019; 80(02): 214-224
DOI: 10.1055/s-0039-1677865
Invited Review
Georg Thieme Verlag KG Stuttgart · New York

Challenges of Hearing Rehabilitation after Radiation and Chemotherapy

Marc-Elie Nader 
1   Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
,
Paul W. Gidley
1   Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
› Institutsangaben
Weitere Informationen

Publikationsverlauf

14. April 2018

14. Dezember 2018

Publikationsdatum:
04. Februar 2019 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Radiation and chemotherapy are frequently used in the treatment of head and neck malignancies. Ototoxicity is a common adverse effect of these treatment modalities. This article discusses the patterns of hearing loss following chemotherapy and radiation therapy. Specific issues related to hearing rehabilitation in oncological patients will also be covered, such as controversies regarding treatment of radiation-induced serous otitis media, risks of otologic surgery, and the use of osseointegrated hearing aids and cochlear implants.

Keywords

hearing loss - ototoxicity - chemotherapy - radiation therapy - otitis media - osseointegrated implant - cochlear implant - temporal bone - cancer - myringotomy
 

  • References

  • 1 Hilal-Dandan R, Brunton LL. Cytotoxic Agents. New York, NY: McGraw-Hill Education; 2016. . Available at: hemonc.mhmedical.com/content.aspx?aid=1127554849
    Google Scholar
  • 2 Gidley PW, DeMonte F. Temporal bone malignancies. Neurosurg Clin N Am 2013; 24 (01) 97-110
    CrossrefPubMedGoogle Scholar
  • 3 Piel IJ, Meyer D, Perlia CP, Wolfe VI. Effects of cis-diamminedichloroplatinum (NSC-119875) on hearing function in man. Cancer Chemother Rep 1974; 58 (06) 871-875
    PubMedGoogle Scholar
  • 4 Landier W. Ototoxicity and cancer therapy. Cancer 2016; 122 (11) 1647-1658
    CrossrefPubMedGoogle Scholar
  • 5 Bertolini P, Lassalle M, Mercier G. , et al. Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss. J Pediatr Hematol Oncol 2004; 26 (10) 649-655
    CrossrefPubMedGoogle Scholar
  • 6 Grewal S, Merchant T, Reymond R, McInerney M, Hodge C, Shearer P. Auditory late effects of childhood cancer therapy: a report from the Children's Oncology Group. Pediatrics 2010; 125 (04) e938-e950
    CrossrefPubMedGoogle Scholar
  • 7 Li Y, Womer RB, Silber JH. Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose. Eur J Cancer 2004; 40 (16) 2445-2451
    CrossrefPubMedGoogle Scholar
  • 8 Kamogashira T, Fujimoto C, Yamasoba T. Reactive oxygen species, apoptosis, and mitochondrial dysfunction in hearing loss. BioMed Res Int 2015; 2015: 617207
    CrossrefPubMedGoogle Scholar
  • 9 Hoistad DL, Ondrey FG, Mutlu C, Schachern PA, Paparella MM, Adams GL. Histopathology of human temporal bone after cis-platinum, radiation, or both. Otolaryngol Head Neck Surg 1998; 118 (06) 825-832
    CrossrefPubMedGoogle Scholar
  • 10 Breglio AM, Rusheen AE, Shide ED. , et al. Cisplatin is retained in the cochlea indefinitely following chemotherapy. Nat Commun 2017; 8 (01) 1654
    CrossrefPubMedGoogle Scholar
  • 11 Brock PR, Bellman SC, Yeomans EC, Pinkerton CR, Pritchard J. Cisplatin ototoxicity in children: a practical grading system. Med Pediatr Oncol 1991; 19 (04) 295-300
    CrossrefPubMedGoogle Scholar
  • 12 Schmidt CM, Bartholomäus E, Deuster D, Heinecke A, Dinnesen AG. The “Muenster classification” of high frequency hearing loss following cisplatin chemotherapy [in German]. HNO 2007; 55 (04) 299-306
    CrossrefPubMedGoogle Scholar
  • 13 Chang KW, Chinosornvatana N. Practical grading system for evaluating cisplatin ototoxicity in children. J Clin Oncol 2010; 28 (10) 1788-1795
    CrossrefPubMedGoogle Scholar
  • 14 Theunissen EA, Dreschler WA, Latenstein MN. , et al. A new grading system for ototoxicity in adults. Ann Otol Rhinol Laryngol 2014; 123 (10) 711-718
    CrossrefPubMedGoogle Scholar
  • 15 Sakamoto M, Kaga K, Kamio T. Extended high-frequency ototoxicity induced by the first administration of cisplatin. Otolaryngol Head Neck Surg 2000; 122 (06) 828-833
    CrossrefPubMedGoogle Scholar
  • 16 Reddel RR, Kefford RF, Grant JM, Coates AS, Fox RM, Tattersall MH. Ototoxicity in patients receiving cisplatin: importance of dose and method of drug administration. Cancer Treat Rep 1982; 66 (01) 19-23
    PubMedGoogle Scholar
  • 17 Crabb SJ, Martin K, Abab J. , et al. COAST (cisplatin ototoxicity attenuated by aspirin trial): a phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss. Eur J Cancer 2017; 87: 75-83
    CrossrefPubMedGoogle Scholar
  • 18 Landier W, Knight K, Wong FL. , et al. Ototoxicity in children with high-risk neuroblastoma: prevalence, risk factors, and concordance of grading scales--a report from the Children's Oncology Group. J Clin Oncol 2014; 32 (06) 527-534
    PubMedGoogle Scholar
  • 19 Dalton DS, Cruickshanks KJ, Klein BE, Klein R, Wiley TL, Nondahl DM. The impact of hearing loss on quality of life in older adults. Gerontologist 2003; 43 (05) 661-668
    CrossrefPubMedGoogle Scholar
  • 20 Gurney JG, Tersak JM, Ness KK, Landier W, Matthay KK, Schmidt ML. ; Children's Oncology Group. Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: a report from the Children's Oncology Group. Pediatrics 2007; 120 (05) e1229-e1236
    CrossrefPubMedGoogle Scholar
  • 21 Blazer DG, Domnitz S, Liverman CT. , eds. Hearing Health Care for Adults: Priorities for Improving Access and Affordability. Washington, DC: National Academies Press; 2016
    Google Scholar
  • 22 Ishikawa E, Sugimoto H, Hatano M. , et al. Protective effects of sodium thiosulfate for cisplatin-mediated ototoxicity in patients with head and neck cancer. Acta Otolaryngol 2015; 135 (09) 919-924
    CrossrefPubMedGoogle Scholar
  • 23 Villani V, Zucchella C, Cristalli G. , et al. Vitamin E neuroprotection against cisplatin ototoxicity: preliminary results from a randomized, placebo-controlled trial. Head Neck 2016; 38 (Suppl. 01) E2118-E2121
    CrossrefPubMedGoogle Scholar
  • 24 Marshak T, Steiner M, Kaminer M, Levy L, Shupak A. Prevention of cisplatin-induced hearing loss by intratympanic dexamethasone: a randomized controlled study. Otolaryngol Head Neck Surg 2014; 150 (06) 983-990
    CrossrefPubMedGoogle Scholar
  • 25 Nader ME, Théorêt Y, Saliba I. The role of intratympanic lactate injection in the prevention of cisplatin-induced ototoxicity. Laryngoscope 2010; 120 (06) 1208-1213
    CrossrefPubMedGoogle Scholar
  • 26 Lavigne P, Lavigne F, Saliba I. Sustained inner ear steroid delivery via bioabsorbable stent: a tolerability and feasibility study on guinea pigs. Otolaryngol Head Neck Surg 2016; 155 (04) 649-653
    CrossrefPubMedGoogle Scholar
  • 27 Adelstein D, Gillison ML, Pfister DG. , et al. NCCN guidelines insights: head and neck cancers, version 2.2017. J Natl Compr Canc Netw 2017; 15 (06) 761-770
    CrossrefPubMedGoogle Scholar
  • 28 Trotti A. Toxicity in head and neck cancer: a review of trends and issues. Int J Radiat Oncol Biol Phys 2000; 47 (01) 1-12
    CrossrefPubMedGoogle Scholar
  • 29 Ondrey FG, Greig JR, Herscher L. Radiation dose to otologic structures during head and neck cancer radiation therapy. Laryngoscope 2000; 110 (2, Pt 1): 217-221
    CrossrefPubMedGoogle Scholar
  • 30 Lambert EM, Gunn GB, Gidley PW. Effects of radiation on the temporal bone in patients with head and neck cancer. Head Neck 2016; 38 (09) 1428-1435
    CrossrefPubMedGoogle Scholar
  • 31 Bhandare N, Antonelli PJ, Morris CG, Malayapa RS, Mendenhall WM. Ototoxicity after radiotherapy for head and neck tumors. Int J Radiat Oncol Biol Phys 2007; 67 (02) 469-479
    CrossrefPubMedGoogle Scholar
  • 32 Jereczek-Fossa BA, Zarowski A, Milani F, Orecchia R. Radiotherapy-induced ear toxicity. Cancer Treat Rev 2003; 29 (05) 417-430
    CrossrefPubMedGoogle Scholar
  • 33 Gyorkey J, Pollock FJ. Radiation necrosis of the ossicles. AMA Arch Otolaryngol 1960; 71: 793-796
    CrossrefPubMedGoogle Scholar
  • 34 Tang NL, Choy AT, John DG, van Hasselt CA. The otological status of patients with nasopharyngeal carcinoma after megavoltage radiotherapy. J Laryngol Otol 1992; 106 (12) 1055-1058
    CrossrefPubMedGoogle Scholar
  • 35 Low WK, Fong KW. Long-term post-irradiation middle ear effusion in nasopharyngeal carcinoma. Auris Nasus Larynx 1998; 25 (03) 319-321
    CrossrefPubMedGoogle Scholar
  • 36 Kew J, King AD, Leung SF. , et al. Middle ear effusions after radiotherapy: correlation with pre-radiotherapy nasopharyngeal tumor patterns. Am J Otol 2000; 21 (06) 782-785
    PubMedGoogle Scholar
  • 37 Hsin CH, Chen TH, Liang KL, Tseng HC, Liu WS. Postirradiation otitis media with effusion in nasopharyngeal carcinoma patients treated by intensity-modulated radiotherapy. Laryngoscope 2013; 123 (09) 2148-2153
    CrossrefPubMedGoogle Scholar
  • 38 Liang KL, Su MC, Twu CW, Jiang RS, Lin JC, Shiao JY. Long-term result of management of otitis media with effusion in patients with post-irradiated nasopharyngeal carcinoma. Eur Arch Otorhinolaryngol 2011; 268 (02) 213-217
    CrossrefPubMedGoogle Scholar
  • 39 Hsin CH, Tseng HC, Lin HP, Chen TH. Post-irradiation otitis media, rhinosinusitis, and their interrelationship in nasopharyngeal carcinoma patients treated by IMRT. Eur Arch Otorhinolaryngol 2016; 273 (02) 471-477
    CrossrefPubMedGoogle Scholar
  • 40 Elwany S. Delayed ultrastructural radiation induced changes in the human mesotympanic middle ear mucosa. J Laryngol Otol 1985; 99 (04) 343-353
    CrossrefPubMedGoogle Scholar
  • 41 Panossian D, Jung TT, Weeks D. , et al. Effect of the radioprotector WR2721 on irradiation-induced injury to ciliated cells of eustachian tube. Ann Otol Rhinol Laryngol 1992; 101 (05) 395-402
    CrossrefPubMedGoogle Scholar
  • 42 Wang SZ, Wang WF, Zhang HY, Guo M, Hoffman MR, Jiang JJ. Analysis of anatomical factors controlling the morbidity of radiation-induced otitis media with effusion. Radiother Oncol 2007; 85 (03) 463-468
    CrossrefPubMedGoogle Scholar
  • 43 Walker GV, Ahmed S, Allen P. , et al. Radiation-induced middle ear and mastoid opacification in skull base tumors treated with radiotherapy. Int J Radiat Oncol Biol Phys 2011; 81 (05) e819-e823
    CrossrefPubMedGoogle Scholar
  • 44 Bass JK, Hua CH, Huang J. , et al. Hearing loss in patients who received cranial radiation therapy for childhood cancer. J Clin Oncol 2016; 34 (11) 1248-1255
    CrossrefPubMedGoogle Scholar
  • 45 Li JJ, Guo YK, Tang QL. , et al. Prospective study of sensorineural hearing loss following radiotherapy for nasopharyngeal carcinoma. J Laryngol Otol 2010; 124 (01) 32-36
    CrossrefPubMedGoogle Scholar
  • 46 Chi FH, Young YH. Inner ear deficits in irradiated nasopharyngeal carcinoma survivors. Laryngoscope 2015; 125 (11) 2565-2571
    CrossrefPubMedGoogle Scholar
  • 47 Scobioala S, Parfitt R, Matulat P. , et al. Impact of radiation technique, radiation fraction dose, and total cisplatin dose on hearing : Retrospective analysis of 29 medulloblastoma patients. Strahlenther Onkol 2017; 193 (11) 910-920
    CrossrefPubMedGoogle Scholar
  • 48 Wang LF, Kuo WR, Ho KY, Lee KW, Lin CS. A long-term study on hearing status in patients with nasopharyngeal carcinoma after radiotherapy. Otol Neurotol 2004; 25 (02) 168-173
    CrossrefPubMedGoogle Scholar
  • 49 Theunissen EA, Bosma SC, Zuur CL. , et al. Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: a systematic review of the literature. Head Neck 2015; 37 (02) 281-292
    CrossrefPubMedGoogle Scholar
  • 50 Mujica-Mota M, Waissbluth S, Daniel SJ. Characteristics of radiation-induced sensorineural hearing loss in head and neck cancer: a systematic review. Head Neck 2013; 35 (11) 1662-1668
    CrossrefPubMedGoogle Scholar
  • 51 Herrmann F, Dörr W, Müller R, Herrmann T. A prospective study on radiation-induced changes in hearing function. Int J Radiat Oncol Biol Phys 2006; 65 (05) 1338-1344
    CrossrefPubMedGoogle Scholar
  • 52 Hitchcock YJ, Tward JD, Szabo A, Bentz BG, Shrieve DC. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys 2009; 73 (03) 779-788
    CrossrefPubMedGoogle Scholar
  • 53 Pan CC, Eisbruch A, Lee JS, Snorrason RM, Ten Haken RK, Kileny PR. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys 2005; 61 (05) 1393-1402
    CrossrefPubMedGoogle Scholar
  • 54 Bohne BA, Marks JE, Glasgow GP. Delayed effects of ionizing radiation on the ear. Laryngoscope 1985; 95 (7, Pt 1): 818-828
    PubMedGoogle Scholar
  • 55 Low WK, Tan MG, Chua AW, Sun L, Wang DY. 12th Yahya Cohen Memorial Lecture: the cellular and molecular basis of radiation-induced sensori-neural hearing loss. Ann Acad Med Singapore 2009; 38 (01) 91-94
    PubMedGoogle Scholar
  • 56 Leach W. Irradiation of the ear. J Laryngol Otol 1965; 79 (10) 870-880
    CrossrefPubMedGoogle Scholar
  • 57 Schuknecht HF, Karmody CS. Radionecrosis of the temporal bone. Laryngoscope 1966; 76 (08) 1416-1428
    PubMedGoogle Scholar
  • 58 Asenov DR, Kaga K, Tsuzuku T. Changes in the audiograms of a nasopharyngeal cancer patient during the course of treatment: a temporal bone histopathological study. Acta Otolaryngol 2007; 127 (10) 1105-1110
    CrossrefPubMedGoogle Scholar
  • 59 Low WK, Tan MG, Sun L, Chua AW, Goh LK, Wang DY. Dose-dependant radiation-induced apoptosis in a cochlear cell-line. Apoptosis 2006; 11 (12) 2127-2136
    CrossrefPubMedGoogle Scholar
  • 60 Rybak LP, Whitworth CA. Ototoxicity: therapeutic opportunities. Drug Discov Today 2005; 10 (19) 1313-1321
    CrossrefPubMedGoogle Scholar
  • 61 Shah JO, Herrera SJ, Roberts DB, Gunn GB, Gidley PW. Complications of tympanostomy tubes in head and neck cancer patients. Am J Otolaryngol 2016; 37 (04) 356-361
    CrossrefPubMedGoogle Scholar
  • 62 Xu YD, Ou YK, Zheng YQ, Chen Y, Ji SF. The treatment for postirradiation otitis media with effusion: a study of three methods. Laryngoscope 2008; 118 (11) 2040-2043
    CrossrefPubMedGoogle Scholar
  • 63 Ho WK, Wei WI, Kwong DL. , et al. Randomized evaluation of the audiologic outcome of ventilation tube insertion for middle ear effusion in patients with nasopharyngeal carcinoma. J Otolaryngol 2002; 31 (05) 287-293
    CrossrefPubMedGoogle Scholar
  • 64 Chen CY, Young YH, Hsu WC, Hsu MM. Failure of grommet insertion in post-irradiation otitis media with effusion. Ann Otol Rhinol Laryngol 2001; 110 (08) 746-748
    CrossrefPubMedGoogle Scholar
  • 65 Young YH, Lu YC. Mechanism of hearing loss in irradiated ears: a long-term longitudinal study. Ann Otol Rhinol Laryngol 2001; 110 (10) 904-906
    CrossrefPubMedGoogle Scholar
  • 66 Morton RP, Woollons AC, McIvor NP. Nasopharyngeal carcinoma and middle ear effusion: natural history and the effect of ventilation tubes. Clin Otolaryngol Allied Sci 1994; 19 (06) 529-531
    CrossrefPubMedGoogle Scholar
  • 67 Soo G, Tong MC, Tsang WS. , et al. The BAHA hearing system for hearing-impaired postirradiated nasopharyngeal cancer patients: a new indication. Otol Neurotol 2009; 30 (04) 496-501
    CrossrefPubMedGoogle Scholar
  • 68 Kuo CL, Wang MC, Chu CH, Shiao AS. New therapeutic strategy for treating otitis media with effusion in postirradiated nasopharyngeal carcinoma patients. J Chin Med Assoc 2012; 75 (07) 329-334
    CrossrefPubMedGoogle Scholar
  • 69 Schwarz Y, Manogaran M, Daniel SJ. Ventilation tubes in middle ear effusion post-nasopharyngeal carcinoma radiation: To insert or not?. Laryngoscope 2016; 126 (12) 2649-2651
    CrossrefPubMedGoogle Scholar
  • 70 Silvola J, Kivekäs I, Poe DS. Balloon dilation of the cartilaginous portion of the eustachian tube. Otolaryngol Head Neck Surg 2014; 151 (01) 125-130
    CrossrefPubMedGoogle Scholar
  • 71 Kapadia M, Tarabichi M. Feasibility and safety of transtympanic balloon dilatation of eustachian tube. Otol Neurotol 2018; 39 (09) e825-e830
    CrossrefPubMedGoogle Scholar
  • 72 Huisman JML, Verdam FJ, Stegeman I, de Ru JA. Treatment of eustachian tube dysfunction with balloon dilation: a systematic review. Laryngoscope 2018; 128 (01) 237-247
    CrossrefPubMedGoogle Scholar
  • 73 O'Neill JV, Katz AH, Skolnik EM. Otologic complications of radiation therapy. Otolaryngol Head Neck Surg (1979) 1979; 87 (03) 359-363
    CrossrefPubMedGoogle Scholar
  • 74 Stone HB, Coleman CN, Anscher MS, McBride WH. Effects of radiation on normal tissue: consequences and mechanisms. Lancet Oncol 2003; 4 (09) 529-536
    CrossrefPubMedGoogle Scholar
  • 75 Bennett M, Kaylie D, Warren F, Jackson CG. Chronic ear surgery in irradiated temporal bones. Laryngoscope 2007; 117 (07) 1240-1244
    CrossrefPubMedGoogle Scholar
  • 76 Hsu YC, Su CY. Tympanoplasty for chronic otitis media in post-irradiated nasopharyngeal carcinoma patients. Ann Otol Rhinol Laryngol 2006; 115 (05) 330-333
    CrossrefPubMedGoogle Scholar
  • 77 Yuen PW, Wei WI. Tympanomastoidectomy for chronic suppurative otitis media of irradiated ears of nasopharyngeal carcinoma patients. J Otolaryngol 1994; 23 (04) 302-304
    PubMedGoogle Scholar
  • 78 Jegoux F, Malard O, Goyenvalle E, Aguado E, Daculsi G. Radiation effects on bone healing and reconstruction: interpretation of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 109 (02) 173-184
    CrossrefPubMedGoogle Scholar
  • 79 Ihde S, Kopp S, Gundlach K, Konstantinović VS. Effects of radiation therapy on craniofacial and dental implants: a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 107 (01) 56-65
    CrossrefPubMedGoogle Scholar
  • 80 Granström G. Osseointegration in irradiated cancer patients: an analysis with respect to implant failures. J Oral Maxillofac Surg 2005; 63 (05) 579-585
    CrossrefPubMedGoogle Scholar
  • 81 Abu-Serriah MM, McGowan DA, Moos KF, Bagg J. Extra-oral craniofacial endosseous implants and radiotherapy. Int J Oral Maxillofac Surg 2003; 32 (06) 585-592
    CrossrefPubMedGoogle Scholar
  • 82 Nader ME, Beadle BM, Roberts DB, Gidley PW. Outcomes and complications of osseointegrated hearing aids in irradiated temporal bones. Laryngoscope 2016; 126 (05) 1187-1192
    CrossrefPubMedGoogle Scholar
  • 83 Wilkie MD, Lightbody KA, Salamat AA, Chakravarthy KM, Luff DA, Temple RH. Stability and survival of bone-anchored hearing aid implant systems in post-irradiated patients. Eur Arch Otorhinolaryngol 2015; 272 (06) 1371-1376
    CrossrefPubMedGoogle Scholar
  • 84 Kiringoda R, Lustig LR. A meta-analysis of the complications associated with osseointegrated hearing aids. Otol Neurotol 2013; 34 (05) 790-794
    CrossrefPubMedGoogle Scholar
  • 85 Beumer III J, Roumanas E, Nishimura R. Advances in osseointegrated implants for dental and facial rehabilitation following major head and neck surgery. Semin Surg Oncol 1995; 11 (03) 200-207
    CrossrefPubMedGoogle Scholar
  • 86 Al-Mahalawy H, Marei HF, Abuohashish H, Alhawaj H, Alrefaee M, Al-Jandan B. Effects of cisplatin chemotherapy on the osseointegration of titanium implants. J Craniomaxillofac Surg 2016; 44 (04) 337-346
    CrossrefPubMedGoogle Scholar
  • 87 Wazen JJ, Young DL, Farrugia MC. , et al. Successes and complications of the Baha system. Otol Neurotol 2008; 29 (08) 1115-1119
    CrossrefPubMedGoogle Scholar
  • 88 Holgers KM, Tjellström A, Bjursten LM, Erlandsson BE. Soft tissue reactions around percutaneous implants: a clinical study of soft tissue conditions around skin-penetrating titanium implants for bone-anchored hearing aids. Am J Otol 1988; 9 (01) 56-59
    Google Scholar
  • 89 Chen SY, Mancuso D, Lalwani AK. Skin necrosis after implantation with the BAHA attract: a case report and review of the literature. Otol Neurotol 2017; 38 (03) 364-367
    CrossrefPubMedGoogle Scholar
  • 90 Greene JS, Giddings NA, Jacobson JT. Effect of irradiation on guinea pig ABR thresholds. Otolaryngol Head Neck Surg 1992; 107 (6, Pt 1): 763-768
    CrossrefPubMedGoogle Scholar
  • 91 Low WK, Burgess R, Fong KW, Wang DY. Effect of radiotherapy on retro-cochlear auditory pathways. Laryngoscope 2005; 115 (10) 1823-1826
    CrossrefPubMedGoogle Scholar
  • 92 Soh JM, D'Souza VD, Sarepaka GK, Ng WN, Ong CS, Low WK. cochlear implant outcomes: a comparison between irradiated and non-irradiated ears. Clin Exp Otorhinolaryngol 2012; 5 (Suppl. 01) S93-S98
    CrossrefPubMedGoogle Scholar
  • 93 Roland Jr JT, Cosetti M, Liebman T, Waltzman S, Allen JC. Cochlear implantation following treatment for medulloblastoma. Laryngoscope 2010; 120 (01) 139-143
    CrossrefPubMedGoogle Scholar
  • 94 Low WK, Gopal K, Goh LK, Fong KW. Cochlear implantation in postirradiated ears: outcomes and challenges. Laryngoscope 2006; 116 (07) 1258-1262
    CrossrefPubMedGoogle Scholar
  • 95 Yue V, Leung EK, Wong TK, Tong MC, Van Hasselt CA. Cochlear implantation for post-irradiation deafness. Cochlear Implants Int 2004; 5 (Suppl. 01) 165-168
    CrossrefPubMedGoogle Scholar
  • 96 Adunka OF, Buchman CA. Cochlear implantation in the irradiated temporal bone. J Laryngol Otol 2007; 121 (01) 83-86
    CrossrefPubMedGoogle Scholar
  • 97 Chua DY, Tan HK. Successful rehabilitation with cochlear implant in post-irradiation induced hearing loss in nasopharyngeal carcinoma patient. Ann Acad Med Singapore 2007; 36 (01) 74-77
    PubMedGoogle Scholar
  • 98 Biggs ND, Ramsden RT. Cochlear implantation in a previously irradiated temporal bone--a case report. Cochlear Implants Int 2001; 2 (02) 129-134
    PubMedGoogle Scholar
  • 99 Formanek M, Czerny C, Gstoettner W, Kornfehl J. Cochlear implantation as a successful rehabilitation for radiation-induced deafness. Eur Arch Otorhinolaryngol 1998; 255 (04) 175-178
    CrossrefPubMedGoogle Scholar
  • 100 Carlson ML, Neff BA, Link MJ. , et al. Magnetic resonance imaging with cochlear implant magnet in place: safety and imaging quality. Otol Neurotol 2015; 36 (06) 965-971
    CrossrefPubMedGoogle Scholar
  • 101 Walton J, Donnelly NP, Tam YC. , et al. MRI without magnet removal in neurofibromatosis type 2 patients with cochlear and auditory brainstem implants. Otol Neurotol 2014; 35 (05) 821-825
    CrossrefPubMedGoogle Scholar
  • 102 Gubbels SP, McMenomey SO. Safety study of the cochlear nucleus 24 device with internal magnet in the 1.5 tesla magnetic resonance imaging scanner. Laryngoscope 2006; 116 (06) 865-871
    PubMedGoogle Scholar
  • 103 Guevara N, Gérard A, Dupré J. , et al. Influence of ionizing radiation on two generations of cochlear implants. BioMed Res Int 2015; 2015: 609607
    PubMedGoogle Scholar
  • 104 Klenzner T, Knapp F, Röhner F. , et al. Influence of ionizing radiation on nucleus 24 cochlear implants. Otol Neurotol 2005; 26 (04) 661-667
    CrossrefPubMedGoogle Scholar
  • 105 Markiewicz M, Giebel S, Wyleioł I. , et al. Allogeneic bone marrow transplantation with total body irradiation-based conditioning in acute lymphoblastic leukemia patient with Cochlear implant. Ann Transplant 2006; 11 (02) 21-22 , discussion 32–43
    PubMedGoogle Scholar
  • 106 Reddy K, Cook B, Shaw C. , et al. Intact performance of a cochlear implant following radiotherapy in a child with acute lymphoblastic leukemia. Pract Radiat Oncol 2012; 2 (03) 233-236
    CrossrefPubMedGoogle Scholar
  • 107 Ryu NG, Moon IJ, Chang YS. , et al. Cochlear implantation for profound hearing loss after multimodal treatment for neuroblastoma in children. Clin Exp Otorhinolaryngol 2015; 8 (04) 329-334
    CrossrefPubMedGoogle Scholar
  • 108 Harris MS, Gilbert JL, Lormore KA, Musunuru SA, Fritsch MH. Cisplatin ototoxicity affecting cochlear implant benefit. Otol Neurotol 2011; 32 (06) 969-972
    CrossrefPubMedGoogle Scholar